Stock Price Quote

EVEREST ORGANICS LTD.

NSE : NABSE : 524790ISIN CODE : INE334C01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE407.859.1 (+2.28 %)
PREV CLOSE ( ) 398.75
OPEN PRICE ( ) 417.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 7241
TODAY'S LOW / HIGH ( )395.00 418.65
52 WK LOW / HIGH ( ) 114.3477
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-02 1993
Management Info
Prasad Venkata Satya Sundara Srikakolapu - Chairman Sri Kakarlapudi Sirisha - Managing Director
Registered Office

Address Aroor Village,Sadasivpet Mandal,Sanga Reddy,
Medak Dist,
Telangana-502291

Phone 08455-250186, 250113, 250115

Email eolcs0405@gmail.com

Website www.everestorganicsltd.com

Registrars Details
Venture Capital & Corporate Investments Ltd
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad
Listing : BSE

NEWS

03Oct Everest Organics informs about special
Everest Organics has informed that it enclosed the summary for the month..
06Sep Everest Organics informs about newspap
Pursuant to Regulation 47 of the Securities and Exchange Board of India..
30Aug Everest Organics informs about press r
Everest Organics has informed that it attached copies of the advertiseme..
08Aug Everest Organics informs about press r
Everest Organics has informed that it enclosed copies of the Newspaper A..
27Jun Everest Organics informs about tradin
Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as..

Financials

in Millions
QTR Jun 25 ANNUAL 25
Net Profit14.05-12.8999999999999
Gross Profit 21.64 -32.4199999999999
Operating Profit 49.8679.1000000000001
Net Sales 538.131594.79

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Sanofi Cons. Health (BSE)
peergroup  4986.40 (7.07%)
M.Cap ( in Cr)11483.99
Kwality Pharma (BSE)
peergroup  971.40 (10.24%)
M.Cap ( in Cr)1007.94
Divi's Lab (BSE)
peergroup  6589.65 (1.08%)
M.Cap ( in Cr)174934.50
Strides Pharma Scien (BSE)
peergroup  973.80 (5.44%)
M.Cap ( in Cr)8975.78
Emcure Pharma (BSE)
peergroup  1380.60 (3.10%)
M.Cap ( in Cr)26171.32

Shareholding Pattern

PROMOTERS 59.64%
NON-INSTITUTION 40.34%
FI/BANKS/INSURANCE 0.02%
MUTUAL FUNDS/UTI 0%
GOVERNMENT 0%
FII 0%

About Everest Organics Ltd.

Everest Organics Ltd. was incorporated in the year 1993. Its today's share price is 407.85. Its current market capitalisation stands at Rs 396.04 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1823.66 Cr and Total Income of Rs.1602.11 Cr. The company's management includes Shweta Singh, Venkata Satyanarayana Murthy Vadali, Kirankumar Rampally, Srikakarlapudi Harikrishna, Sri Kakarlapudi Sirisha, Prasad Venkata Satya Sundara Srikakolapu.

It is listed on the BSE with a BSE Code of 524790 , NSE with an NSE Symbol of and ISIN of INE334C01029. It's Registered office is at Aroor Village,Sadasivpet Mandal,Sanga ReddyMedak Dist-502291, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are PSN Ravi Shanker & Associates, PSN Ravishanker & Associates, Suryam & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.